Cytarabine (Cytarabine)

Cytarabine is a cytotoxic drug used to suppress symptoms in some types of leukemia. Prescribed by injection; can cause bone marrow damage and lead to the development of various hematopoietic disorders.

Other side effects of cytarabine include nausea, vomiting, oral ulceration and diarrhea.

Trade names of the drug: Alexan, Cytosar.

Cytarabine is a cytotoxic drug used to treat some types of leukemia, including acute lymphoblastic leukemia (ALL). It is given by injection and can cause bone marrow damage, which can lead to a variety of hematopoietic disorders, including anemia, thrombocytopenia, neutropenia and pancytopenia.

Cytarabine can cause side effects such as nausea, vomiting, oral ulcers, diarrhea, liver dysfunction, anemia, neutropenia and thrombocytopenia, as well as other disorders of the body's organs and systems.

The trade names of the drug are Alexan and Cytosar. Due to its high toxicity and large number of side effects, cytarabine is usually prescribed in a hospital setting and under the supervision of a physician.

Cytarabine is an antitumor agent, a purine derivative, classified as an alkylating chemotherapeutic drug. It is used to treat acute lymphoblastic leukemia, chronic leukemia, hairy cell leukemia and other types of malignant neoplasms, as well as reticuloendothelial tumors. Most cytarabine is excreted unmetabolized by the kidneys within 24 hours; a small amount is metabolized in the liver (less than 5%).